{"date":"2025-11-20","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6730-2025-11-20-1856-17ys96h","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"18:56:40","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日(補充公告)","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-11-20 18:56，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-11-20-1835-1xeooua","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"18:35:37","subject":"公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-11-20 18:35，「公告本公司股票初次上櫃前現金增資認股繳款期間暨暫定承銷價相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-11-20-1835-1bnswtb","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"18:35:09","subject":"公告本公司初次上櫃現金增資委託代收及存儲價款機構","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-11-20 18:35，「公告本公司初次上櫃現金增資委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6730-2025-11-20-1834-qkrt5g","company_id":"6730","company":"常廣","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"18:34:52","subject":"公告本公司股務代理機構名稱、辦公處所及聯絡電話","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：常廣（6730），2025-11-20 18:34，「公告本公司股務代理機構名稱、辦公處所及聯絡電話」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2025-11-20-1823-k67l5o","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2025-11-20","time":"18:23:06","subject":"公告本公司通過日本厚生勞動省細胞培養加工設施查核","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2025-11-20 18:23，「公告本公司通過日本厚生勞動省細胞培養加工設施查核」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-11-20-1552-m843cs","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-11-20","time":"15:52:41","subject":"公告本公司現金增資發行新股案向金管會申請延長募集期間三個月","clause":"第44款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-11-20 15:52，「公告本公司現金增資發行新股案向金管會申請延長募集期間三個月」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-11-20-1539-hq9rr1","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"15:39:24","subject":"公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第三款標準(補8/8公告)","clause":"第22款","fact_date":"2025-08-08","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-11-20 15:39，「公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第三款標準(補8/8公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-11-20-1538-b2av6v","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"15:38:06","subject":"公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款標準(更正114/5/8、11/13公告主旨及內容說明9.之比率)","clause":"第22款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-11-20 15:38，「公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款標準(更正114/5/8、1」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2025-11-20-1452-1t3nl72","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"14:52:40","subject":"公告本公司受邀參加玉山證券所舉辦之法人說明會","clause":"第12款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2025-11-20 14:52，「公告本公司受邀參加玉山證券所舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-11-20-1426-194aq5z","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-11-20","time":"14:26:14","subject":"本公司受邀參加福邦證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-11-28","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-11-20 14:26，「本公司受邀參加福邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-20-1349-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-20","time":"13:49:36","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-20 13:49，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-11-20-1349-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-11-20","time":"13:49:17","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-11-20 13:49，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-11-20-1313-ndyjrq","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-11-20","time":"13:13:06","subject":"澄清理財周刊報導","clause":"第53款","fact_date":"2025-11-20","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-11-20 13:13，「澄清理財周刊報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}